tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Lytix Biopharma AS (DE:6BG)
FRANKFURT:6BG
Germany Market
6BG
Lytix Biopharma AS
Stock Analysis
Technical Analysis
Chart
Earnings
Dividends
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding DE:6BG?
Track your performance easily
Link Broker

Lytix Biopharma AS (6BG) Financial Statements

1 Followers

Lytix Biopharma AS Financial Overview

Lytix Biopharma AS's market cap is currently ―. The company's EPS TTM is €-0.159; its P/E ratio is -3.68; Lytix Biopharma AS is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenuekr 0.00kr 1.41Mkr 0.00kr 0.00kr 0.00
Gross Profit-----
EBITkr -14.09Mkr -17.94Mkr -9.99Mkr -14.67Mkr -16.40M
EBITDAkr -14.08Mkr -17.93Mkr -9.98Mkr -14.67Mkr -16.40M
Net Income Common Stockholderskr -29.19Mkr -11.15Mkr -1.18Mkr -15.23Mkr -16.39M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 145.16Mkr 171.58Mkr 177.08Mkr 180.67Mkr 197.28M
Total Assetskr 152.02Mkr 177.37Mkr 184.11Mkr 187.94Mkr 202.96M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -145.16Mkr -171.58Mkr -177.08Mkr -180.67Mkr -197.28M
Total Liabilitieskr 16.89Mkr 13.49Mkr 10.14Mkr 13.13Mkr 13.34M
Stockholders Equitykr 135.13Mkr 163.88Mkr 173.97Mkr 174.81Mkr 189.62M
Cash Flow-
Free Cash Flowkr -26.42Mkr -5.50Mkr -3.58Mkr -16.75Mkr -11.90M
Operating Cash Flowkr -26.42Mkr -5.49Mkr -3.48Mkr -16.71Mkr -11.90M
Investing Cash Flowkr -698.00Kkr -49.93Mkr -102.00Kkr -35.00K-
Financing Cash Flowkr 0.00kr 0.00kr 0.00kr 133.00Kkr 0.00
Currency in NOK

Lytix Biopharma AS Earnings and Revenue History

Income Statement >

Lytix Biopharma AS Debt to Assets

Balance Sheet >

Lytix Biopharma AS Cash Flow

Cash Flow >

Lytix Biopharma AS Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis
Subscribe NowSee Plans & Pricing